Dynavax Technologies Corp (NASDAQ:DVAX)
| 2.52 Real-Time Quote |  -0.01 / -0.40%Today’s Change | 1.74 Today|||52-Week Range 5.10 | -11.58% Year-to-Date |
Latest DVAX News | Press Releases
No recent news for Dynavax Technologies Corp.
Today’s Trading
| Previous close | 2.53 |
| Today’s open | 2.52 |
| Day’s range | 2.50 - 2.54 |
| Volume | 153,155 |
| Average volume (3 months) | 2,531,114 |
| Market cap | $462.7M |
| Dividend yield | -- |
Data as of 12:04pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | -5.13% |
| Earnings growth (this year) | 0.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -55.06% |
| P/E ratio | NM |
| Price/Sales | 50.01 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HITKHi-Tech Pharmacal Co... | -0.16 | -0.47% |
| SCRSimcere Pharmaceutic... | -0.04 | -0.43% |
| ASTXAstex Pharmaceutical... | +0.08 | +1.56% |
| AVNRAvanir Pharmaceutica... | -0.03 | -0.88% |
Data as of 12:03pm ET, 05/24/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $9.7M |
| Annual profit (last year) | -$69.9M |
| Net profit margin | -720.08% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Eddie J. Gray, MBA |
President, Director & Chief Medical Officer J. Tyler Martin, MD |
Corporate headquarters Berkeley, California |
Forecasts
